All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Study Accrual Status Code | NCIT_C93676 | [A coded value specifying the phase in the lifecycle of the enrollment of subjects to a study.] |
| Unit of Force | NCIT_C69180 | [An indication of the type of unit of measure being used to express the interaction between physical bodies.] |
| ESO-1 Positive Cells Present | NCIT_C69181 | |
| Unit of Surface Tension | NCIT_C69182 | [A unit of the stretching force required to form a liquid film, tending to minimize the area of a surface, surface energy of the liquid per unit length of the film.] |
| Vaccine Potency | NCIT_C69183 | [A quantitative measure of the specific ability of the vaccine product to achieve an intended biological effect defined in a suitable biological assay based on the attribute of the product that is linked to the relevant biological properties.] |
| Pharmaceutical Product Characteristics | NCIT_C43242 | [The distinguishing qualities of a pharmaceutical product or substance.] |
| SKI Gene | NCIT_C69184 | [This gene is involved in transcriptional regulation and is involved in cellular signal transduction.] |
| Transcription Factor Gene | NCIT_C20420 | [Genes that code for transcription factors.] |
| SKI wt Allele | NCIT_C69185 | [Human SKI wild-type allele is located within 1q22-q24 and is approximately 81 kb in length. This allele, which encodes ski oncogene protein, is involved in neural tube development and muscle differentiation. Deletion of the gene may be associated with congenital fiber-type disproportion myopathy and dilated cardiomyopathy. Aberrant elevated expression of the gene may play a role in tumorigenesis.] |
| Study Reference Citation Description | NCIT_C94130 | [A bibliographical reference in a format acceptable to the publisher of the reference material.] |
| Study Protocol Version Planned Study Subject Experience | NCIT_C94120 | [A description of what the study subject can expect to experience over the course of the study, including the sequence and duration of activities.] |
| Planned Study Subject Experience | NCIT_C93626 | [A description of what the study subject can expect to experience over the course of the study, including the sequence and duration of activities.] |
| Patient Allergic to Contrast Media | NCIT_C69197 | [Patient identified to be at risk for an allergic reaction to contrast media.] |
| Adverse Event by Cause | NCIT_C52681 | |
| Study Protocol Version Primary Purpose Code | NCIT_C94121 | [A coded value specifying the type of study based upon the intent of the study's activities.] |
| Primary Purpose Code | NCIT_C93633 | [A coded value specifying the most important reason or intention for an activity, event or entity.] |
| Clockface or Region | NCIT_C69198 | [A location identifier based on clockface numbering or anatomic subregion.] |
| Study Protocol Version Purpose Statement | NCIT_C94122 | [A statement describing the overall rationale of the study. This field describes the contribution of this study to product development, i.e., what knowledge is being contributed from the conduct of this study.] |
| Purpose Statement | NCIT_C93640 | [A statement describing the overall rationale of the activity.] |
| Content Creation Date | NCIT_C69199 | [The date on which data creation began.] |